Stock Analysis on Net
Stock Analysis on Net

Cytokinetics Inc. (NASDAQ:CYTK)

$22.49

This company has been moved to the archive! The financial data has not been updated since November 3, 2023.

Enterprise Value (EV)

Microsoft Excel

Paying users area

Try for free

Cytokinetics Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Current Enterprise Value (EV)

Cytokinetics Inc., current enterprise value calculation

Microsoft Excel
Current share price (P)
No. shares of common stock outstanding
US$ in thousands
Common equity (market value)1
Add: Preferred stock, $0.001 par value; issued and outstanding: none (per books)
Total equity
Add: Current portion of term loan (per books)
Add: Short-term finance lease liabilities (per books)
Add: Term loan, net, excluding current portion (per books)
Add: Convertible notes, net (per books)
Add: Long-term finance lease liabilities (per books)
Total equity and debt
Less: Cash and cash equivalents
Less: Short-term investments
Enterprise value (EV)

Based on: 10-K (reporting date: 2022-12-31).

1 Common equity (market value) = Share price × No. shares of common stock outstanding
= ×

Historical Enterprise Value (EV)

Cytokinetics Inc., EV calculation

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Share price1, 2
No. shares of common stock outstanding1
US$ in thousands
Common equity (market value)3
Add: Preferred stock, $0.001 par value; issued and outstanding: none (book value)
Total equity
Add: Current portion of term loan (book value)
Add: Short-term finance lease liabilities (book value)
Add: Term loan, net, excluding current portion (book value)
Add: Convertible notes, net (book value)
Add: Long-term finance lease liabilities (book value)
Total equity and debt
Less: Cash and cash equivalents
Less: Short-term investments
Enterprise value (EV)

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 Data adjusted for splits and stock dividends.

2 Closing price as at the filing date of Cytokinetics Inc. Annual Report.

3 2022 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= ×

Item Description The company
EV Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments. Cytokinetics Inc. EV increased from 2020 to 2021 and from 2021 to 2022.